Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investors! We’re approaching the end of trading for the week but we’ve got one more day of market coverage to bring you. Of course, we’re starting that off with a look at the biggest pre-m...
Gainers: Aethlon Medical AEMD +425%, Checkpoint Therapeutics CKPT +26%, Adamis Pharmaceuticals ADMP +12%, SCWorx (WORX) +18%, ZIOPHARM Oncology ZIOP +15%.Losers: Atossa Therapeutics ATOS -14%, CEL-SCI CVM -11%, Precipio (PR...
Gainers: Clover Health Investments CLOV +70%, Precipio PRPO +15%, GBS (GBS) +15%, PDS Biotechnology PDSB +15%, Cyclerion Therapeutics CYCN +10%.Losers: Ra Medical Systems RMED -19%, HOOKIPA Pharma HOOK -15%, AC Immune (ACIU...
NEW YORK, June 08, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced survey results from more than 300 patients globally as part...
GBS (GBS): Q1 GAAP EPS of -$0.27.Cash, cash equivalents, and marketable securities of $14.2M.Press Release For further details see: GBS reports Q1 results
- Anticipate Emergency Use Submission for SARS-CoV-2 Antibody Biosensor Test in the Second Half of 2021- - $14 Million in Cash, Cash Equivalents, and Marketable Securities as of March 31, 2021, Provides Runway into the Second Half of 2022 - - Established a Point-of-C...
Chiasma (CHMA) +39% on Q1 results.Athenex (ATNX) +31% on Kuur Therapeutics acquisition.Ault Global Holdings (DPW) +30% on preliminary Q1 results.iBio (IBIO) +26% after resolving Fraunhofer USA lawsuitBig 5 Sporting Goods Corporation (BGFV) +22% on Q1 results.DAVIDsTEA...
Image Sensing Systems (ISNS) -26% on Q1 earnings release.Regional Health Properties (RHE) -21%.Brooklyn ImmunoTherapeutics (BTX) -20%.Ballard Power Systems (BLDP) -13% on Q1 earnings release.SunLink Health Systems (SSY) -10%.Ocugen (OCGN) -11%.iRobot (IRBT) -10% ...
GBS Inc. (NASDAQ:GBS) traded today at a new 52-week low of $4.23. This new low was reached on above average trading volume as 622,000 shares traded hands, while the average 30-day volume is approximately 121,000 shares. GBS Inc. share prices have moved between a 52-week high of $14.24 an...
GBS Inc. (NASDAQ:GBS) traded today at a new 52-week low of $4.16. So far today approximately 622,000 shares have been exchanged, as compared to an average 30-day volume of 247,000 shares. GBS Inc. share prices have moved between a 52-week high of $14.24 and the current low of $4.16 and a...
News, Short Squeeze, Breakout and More Instantly...
GBS Inc. Company Name:
GBS Stock Symbol:
NASDAQ Market:
The transaction further solidifies GBS’ leadership in non-invasive, real-time diagnostic testing with an expanded portfolio and geographical reach GBS’ global footprint includes operations in Australia, United Kingdom and the US NEW YORK, Oct. 04, 2022 (G...
- Entered into exclusive agreement with Intelligent Fingerprinting Ltd. (IFP) for screening technology focused on drugs of abuse towards a prospective acquisition - - Completed collection and analysis in a study with coincidental sampling of oral fluid and blood to evaluate the ...
NEW YORK, Aug. 29, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that it will release its financial results for the four...